Zhejiang, China

Zongquan Li




Average Co-Inventor Count = 4.4

ph-index = 1


Company Filing History:


Years Active: 2015-2025

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Title: Zongquan Li: Innovator in Pharmaceutical Chemistry

Introduction

Zongquan Li is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds and methods for their preparation. With a total of two patents to his name, Li's work is recognized for its potential impact on medical treatments.

Latest Patents

Li's latest patents include groundbreaking inventions related to polymorphs of a kinase inhibitor and methods for preparing Icotinib and its hydrochloride form. The first patent focuses on new crystal forms of a specific compound, which has applications in the treatment of various diseases. This invention not only details the preparation methods but also emphasizes the pharmaceutical compositions that can be derived from these compounds. The second patent presents environmentally friendly methods for synthesizing Icotinib, avoiding harmful chemicals and reducing pollution, which is beneficial for both the economy and the environment.

Career Highlights

Throughout his career, Zongquan Li has worked with prominent companies in the pharmaceutical industry, including Meryx, Inc. and Betta Pharmaceuticals Co., Ltd. His experience in these organizations has allowed him to collaborate on various innovative projects that aim to enhance drug development processes.

Collaborations

Li has collaborated with notable colleagues in his field, including Xiaodong Wang and Weihe Zhang. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Zongquan Li is a distinguished inventor whose work in pharmaceutical chemistry has the potential to revolutionize treatment methods for various diseases. His innovative patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…